SCT for Wilms' tumour

Bone Marrow Transplantation

Volumn 41, Issue SUPPL. 2, 2008, Pages

  Dallorso, S ^a   Dini, G ^a   Faraci, M ^a   Spreafico, F ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; THIOTEPA; TOPOTECAN;

ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD TOXICITY; BONE MARROW RESCUE; BRAIN METASTASIS; CANCER REGRESSION; CANCER RELAPSE; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; DATA BASE; DISEASE FREE SURVIVAL; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; EUROPE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; LUNG METASTASIS; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; NEPHRECTOMY; NEPHROBLASTOMA; NEPHROTOXICITY; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES;

ALGORITHMS; CHILD; DISEASE-FREE SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASM RECURRENCE, LOCAL; REMISSION INDUCTION; WILMS TUMOR;

EID: 45749101369     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.70     Document Type: Article

References (12)

1. Metzger ML, Dome JS. Current therapy for Wilms' tumor. Oncologist 2005; 10: 815-826.
2. Pein F, Rey A, de Kraker J, Ludwig R, Pötter R, Godzinsky J et al Multivariate analysis of adverse prognostic factors (APF) in children with recurrent (Rec) Wilms' tumor (WT) after initial treatment according to SIOP-6 or SIOP-9 strategies. Med Pediatr Oncol 1999; 33: 170 (abstract no. 111).
3. Grundy P, Breslow N, Green DM, Sharpies K, Evans A, D'Angio GJ. Prognostic factors for children with recurrent Wilms' Tumor: Results from the second and third National Wilms' Tumor Study. J Clin Oncol 1989: 7: 638-647.
4. Dome JS, LiU T, Krasin M. Lott L, Shearer P, Daw NC et al. Improved survival for patients with recur rent Wilms tumor: The experience at St Jude Children's Research Hospital. J Pediatr Henwtol Oncol 2002: 24: 192-198.
5. Pein F, Tournade MF, Zucker JM, Brunat-Mentigny M, Deville A, Boutard P et al. Etoposide and carboplatin: A highly effective combination in relapsed or refractory Wilms' tumor a phase II study by the French Society of Pediatric Oncology. J Clin Oncol 1994; 12: 931-936.
6. Abu-Ghosh AM, Krailo MD, Goldman SC, Slack RS, Davenport V, Morris E et al. Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: A Children's Cancer Group report. Ann Oncol 2002; 13: 460-469.
7. Garaventa A, Hartmann O, Bernard JL, Zucker JM, Pardo N, Castel V et al. Autologous bone marrow transplantation for pediatric Wilms' tumor: The experience of the European bone marrow transplantation solid tumor registry. Med Pediatr Oncol 1994: 22: 11-14.
8. Kullendorff CM, Bekassy AN. Salvage treatment of relapsing Wilms' tumour by autologous bone marrow transplantation. Eur J Pediatr Surg 1997; 7: 177-179.
9. Pein F, Michon J, Valteau-Couanet D, Quintana E, Frappaz D, Vannier JP et al. High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: A French Society of Pediatric Oncology Study. J Clin Oncol 1998; 16: 3295-3301.
10. Kremens B, Gruhn B, Klingebiel T, Hasan C, Laws HJ, Koscielmak E et al. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma. Bone Marrow Transplant 2002; 30 893-898.
11. Campbell AD, Cohn SL, Reynolds M, Seshadri R, Morgan E, Geissler G et al. Treatment of relapsed Wilms' tumor with high-dose theippy and autologous hematopoietic stem-cell rescue: The experience at Children's Memorial Hospital. J Clin Oncol 2004; 22: S885-2890.
12. Spreafico F, Bisogno G, Collini P, Jenkner A, Gandola L, D'Angelo P et al. Treatment of high-risk relapsed wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell. Support: Experience by the Italian Association of Pediatric Hematology and Oncology. Pediatr Blood Cancer doi: 10.1062/pbc.21521.